Dülgar, Ö. Et Al. 2025. Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study. Journal of Chemotherapy , vol.37, no.4 , 334-340.

Dülgar, Ö., Türker, S., BAŞARAN, G., Araz, M., Sümbül, A. T., Çağlayan, D., ... GÜMÜŞAY, Ö.(2025). Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study. Journal of Chemotherapy , vol.37, no.4, 334-340.

Dülgar, Özgecan Et Al. "Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study," Journal of Chemotherapy , vol.37, no.4, 334-340, 2025

Dülgar, Özgecan Et Al. "Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study." Journal of Chemotherapy , vol.37, no.4, pp.334-340, 2025

Dülgar, Ö. Et Al. (2025) . "Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study." Journal of Chemotherapy , vol.37, no.4, pp.334-340.

@article{article, author={Özgecan Dülgar Et Al. }, title={Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study}, journal={Journal of Chemotherapy}, year=2025, pages={334-340} }